Colgate-Palmolive (NYSE:CL) Price Target Lowered to $100.00 at TD Cowen

Colgate-Palmolive (NYSE:CL) had its target price reduced by TD Cowen from $110.00 to $100.00 in a research report released on Wednesday morning,Benzinga reports. TD Cowen currently has a buy rating on the stock.

Other research analysts also recently issued research reports about the stock. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the company from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. upped their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Wells Fargo & Company reduced their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday. Piper Sandler dropped their price target on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday. Finally, StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Wednesday, January 1st. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $103.63.

Colgate-Palmolive Stock Performance

NYSE CL opened at $87.39 on Wednesday. Colgate-Palmolive has a one year low of $79.69 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. The business has a 50 day simple moving average of $92.89 and a 200 day simple moving average of $98.23. The stock has a market capitalization of $71.40 billion, a P/E ratio of 25.04, a P/E/G ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.29%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 57.31%.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Several large investors have recently modified their holdings of the stock. D Orazio & Associates Inc. increased its position in Colgate-Palmolive by 3.9% in the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the last quarter. Fiducient Advisors LLC raised its stake in Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after acquiring an additional 110 shares during the period. Wealthspire Advisors LLC lifted its holdings in Colgate-Palmolive by 3.0% during the second quarter. Wealthspire Advisors LLC now owns 3,853 shares of the company’s stock valued at $374,000 after purchasing an additional 111 shares during the last quarter. Sequoia Financial Advisors LLC boosted its position in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares during the period. Finally, Evernest Financial Advisors LLC increased its stake in shares of Colgate-Palmolive by 4.0% in the second quarter. Evernest Financial Advisors LLC now owns 2,985 shares of the company’s stock worth $290,000 after purchasing an additional 115 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.